Loading...

Hims & Hers Health, Inc.

HIMSNYSE
Consumer DefensiveHousehold & Personal Products
$51.37
$-0.98(-1.87%)

Hims & Hers Health, Inc. (HIMS) Stock Overview

Explore Hims & Hers Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
69.33%
69.33%
Profit Growth
$0.74
635.28%
EPS Growth
$0.74
627.27%
Operating Margin
6.19%
310.18%
ROE
35.97%
635.28%
Dividend Yield
0.00%

Analyst Recommendations

Strong Buy
0
Buy
5
Hold
4
Sell
6
Strong Sell
0

Price Targets

Low$13.00
Average$24.29
High$68.00

Company Profile

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

CEO

Mr. Andrew Dudum

Employees

1,637

Headquarters

2269 Chestnut Street, San Francisco, CA

Founded

2019

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.